An open label, multicenter, noninterventional study of apatinib in advanced gastric cancer patients (AHEAD-G202)

BACKGROUND: Apatinib has been proved to be effective and well tolerated among patients in phase II and III studies. Here, we evaluated the safety and effectiveness of apatinib in advanced gastric cancer patients in a real-world setting. METHODS: This study enrolled advanced gastric cancer patients w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Med Oncol
Main Authors: Wang, Xiang, Zhang, Ruixing, Du, Nan, Yang, Mudan, Zang, Aimin, Liu, Likun, Yu, Junyan, Gao, Jinghua, Zhang, Junping, Fu, Zhanzhao, Ren, Yuchuan, Ma, Liwen, Guo, Jun, Li, Qingshan, Li, Xiaomei, Fan, Zaiwen, Song, Xiang, Liu, Zheng, Zhang, Yan, Li, Guozhong, Yu, Zhonghe, Diao, Jianfeng, Jia, Junmei, Liang, Feng, Wang, Huaqing, Sun, Junzhong, Gao, Yunge, Yang, Ping, Bai, Chunmei, Ren, Xiubao, Zhong, Diansheng
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7082876/
https://ncbi.nlm.nih.gov/pubmed/32218807
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920905424
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados